How many patents does
The Broad Institute have?
patents
1,424
families
304
granted
128
applications
1,296
WO
431
US
378
EP
200
JP
63
CN
41
KR
30
GB
2
RoW
279
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
The Broad Institute
Top ten assignees appearing on patents
2009 - 2018
| bayer pharma | 26 |
| editas medicine | 13 |
| bayer | 13 |
| severinov, konstantin | 11 |
| novartis | 10 |
| biocistronix | 4 |
| ian slaymaker | 2 |
| espci innov | 2 |
| bear, mark, firman | 1 |
| nanostring technologies | 1 |
2009
2018
| bayer pharma | 16 |
| bayer | 11 |
| editas medicine | 7 |
| severinov, konstantin | 3 |
| novartis | 3 |
| ian slaymaker | 2 |
| biogen ma | 1 |
The Broad Institute
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods, systems, and apparatus for identifying target sequences for cas enzymes or cris… 🛈 | 211 | 2012 |
| delivery, engineering and optimization of tandem guide systems, methods and compositions… 🛈 | 70 | 2013 |
| methods of diagnosing infectious disease pathogens and their drug sensitivity | 23 | 2010 |
| nucleotide-specific recognition sequences for designer tal effectors | 22 | 2011 |
| compositions and methods of use of crispr-cas systems in nucleotide repeat disorders | 22 | 2013 |
| novel crispr enzymes and systems | 19 | 2015 |
| crispr-cas systems and methods for altering expression of gene products, structural info… 🛈 | 18 | 2013 |
| shared neoantigens | 17 | 2015 |
| inhibitors of histone deacetylase | 17 | 2011 |
| delivery, use and therapeutic applications of the crispr-cas systems and compositions fo… 🛈 | 16 | 2013 |